Max-Planck-Institute for Medical Research, Jahnstrasse 29, 69120, Heidelberg, Germany.
DWI Leibniz Institute for Interactive Materials e.V, RWTH Aachen University, Forckenbeckstrasse 50, 52074, Aachen, Germany.
Adv Healthc Mater. 2024 Apr;13(9):e2303351. doi: 10.1002/adhm.202303351. Epub 2024 Feb 1.
In vitro engineered skin models are emerging as an alternative platform to reduce and replace animal testing in dermatological research. Despite the progress made in recent years, considerable challenges still exist for the inclusion of diverse cell types within skin models. Blood vessels, in particular, are essential in maintaining tissue homeostasis and are one of many primary contributors to skin disease inception and progression. Substantial efforts in the past have allowed the successful fabrication of vascularized skin models that are currently utilized for disease modeling and drugs/cosmetics testing. This review first discusses the need for vascularization within tissue-engineered skin models, highlighting their role in skin grafting and disease pathophysiology. Second, the review spotlights the milestones and recent progress in the fabrication and utilization of vascularized skin models. Additionally, advances including the use of bioreactors, organ-on-a-chip devices, and organoid systems are briefly explored. Finally, the challenges and future outlook for vascularized skin models are addressed.
体外工程皮肤模型作为减少和替代皮肤科研究中动物测试的替代平台正在兴起。尽管近年来取得了进展,但在将多种细胞类型纳入皮肤模型方面仍然存在相当大的挑战。血管在维持组织内稳态方面尤为重要,是许多导致皮肤疾病发生和发展的主要因素之一。过去的大量努力已经成功地制造了血管化的皮肤模型,目前用于疾病建模和药物/化妆品测试。本综述首先讨论了在组织工程皮肤模型中血管化的必要性,强调了其在皮肤移植和疾病病理生理学中的作用。其次,综述重点介绍了血管化皮肤模型的制造和应用的里程碑和最新进展。此外,还简要探讨了包括使用生物反应器、器官芯片装置和类器官系统在内的进展。最后,讨论了血管化皮肤模型面临的挑战和未来展望。